Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety: Healthy Subjects”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01964131
What this trial is testing

BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects

Who this might be right for
Gastric UlcerDuodenal UlcerAnastomotic Ulcer+2 more
AstraZeneca 34
Early research (Phase 1)Study completedNCT01848002
What this trial is testing

Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers

Who this might be right for
Congenital Bleeding DisorderCongenital FXIII DeficiencyHealthy
Novo Nordisk A/S 24
Early research (Phase 1)Study completedNCT06490939
What this trial is testing

Clinical Trial of Efepoetin Alfa in Healthy Subjects

Who this might be right for
Healthy
Genexine, Inc. 40
Early research (Phase 1)Study completedNCT06285201
What this trial is testing

Study of Felzartamab in Healthy Adult Subjects

Who this might be right for
Healthy
TJ Biopharma Co., Ltd. 24
Early research (Phase 1)Study completedNCT00540553
What this trial is testing

Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males

Who this might be right for
Healthy SubjectsAndrogen Deficiency
GlaxoSmithKline 126
Post-approval studies (Phase 4)Study completedNCT03266237
What this trial is testing

The Immune Response to Influenza Vaccinations in Elderly Individuals

Who this might be right for
Influenza
National University Hospital, Singapore 240
Early research (Phase 1)Looking for participantsNCT06565195
What this trial is testing

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Prevail Therapeutics 124
Large-scale testing (Phase 3)Study completedNCT01339312
What this trial is testing

Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies Vaccine

Who this might be right for
RabiesRabies Virus
Sanofi Pasteur, a Sanofi Company 816
Early research (Phase 1)Study completedNCT01915212
What this trial is testing

Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection

Who this might be right for
Healthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID) 69
Early research (Phase 1)Study completedNCT03859219
What this trial is testing

Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcutaneous Infusion in Healthy Japanese, Chinese and Caucasian Study Participants

Who this might be right for
Healthy-volunteers
UCB Biopharma S.P.R.L. 65
Early research (Phase 1)Study completedNCT00435396
What this trial is testing

Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects

Who this might be right for
Infections, Cytomegalovirus
GlaxoSmithKline 40
Early research (Phase 1)Study completedNCT06385327
What this trial is testing

Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 115
Early research (Phase 1)Looking for participantsNCT07682948
What this trial is testing

A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

Who this might be right for
HypertensionDyslipidemia
Korea United Pharm. Inc. 36
Early research (Phase 1)Study completedNCT01907776
What this trial is testing

Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers

Who this might be right for
Healthy
Meiji Seika Pharma Co., Ltd. 56
Early research (Phase 1)Study completedNCT00841048
What this trial is testing

Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses

Who this might be right for
Diabetes Mellitus Type 2
AstraZeneca 107
Early research (Phase 1)Study completedNCT06698926
What this trial is testing

Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants

Who this might be right for
Healthy Volunteer
AbbVie 110
Early research (Phase 1)Study completedNCT02626026
What this trial is testing

Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 42
Early research (Phase 1)Study completedNCT01211626
What this trial is testing

Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)

Who this might be right for
HCV Infection
Hoffmann-La Roche 75
Early research (Phase 1)Study completedNCT00959426
What this trial is testing

A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers

Who this might be right for
ObesityOverweightHealthy
Pfizer 71
Early research (Phase 1)Enrolling By InvitationNCT07182552
What this trial is testing

Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants

Who this might be right for
TED
Nanjing Chia-tai Tianqing Pharmaceutical 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation